Generated Significant 37% Year-over-Year Revenue Growth in Q1 2024

ROSH-HA`AYIN, Israel, May 08, 2024 (GLOBE NEWSWIRE) -- Kornit Digital Ltd. (“Kornit” or the “Company”) (Nasdaq: KRNT), a worldwide market leader in sustainable, on-demand, digital fashion^X and textile production technologies, reported today its results for the first quarter ended March 31, 2024.

VONORE, Tenn., May 08, 2024 (GLOBE NEWSWIRE) -- MasterCraft Boat Holdings, Inc. (NASDAQ: MCFT) today announced financial results for its fiscal 2024 third quarter ended March 31, 2024.

Wemade is at the forefront of the next wave of Web3 game developers that are innovating with blockchain technology. 

 - ATH434-201 Trial on Track to Complete in November 2024 –

FORM 8.5 (EPT/RI)

      May 8, 2024 – Atlantica Sustainable Infrastructure plc (NASDAQ: AY) (“Atlantica” or the “Company”) today reported its financial results for the first quarter of 2024. Revenue for the first quarter of 2024 was $242.9 million, a 0.2% increase compared with the first quarter of 2023. Adjusted EBITDA was $164.2 million, a 0.9% decrease year-over-year excluding the impact of the unscheduled outage at Kaxu¹, and a 5.7% decrease compared to the first quarter of 2023. Operating Cash Flow was $65.6 million, a 57.3% increase compared with $41.7 million in the first quarter of 2023. CAFD was $50.9 million, a 17% decrease compared with $61.0 million in the first quarter of 2023 which included $4.1 million from the sale of part of our equity interest in our development company in Colombia to a partner. CAFD per share⁴ was $0.44, a 17% decrease compared to the same period of the previous year and an 11% decrease excluding the equity sale in Colombia previously mentioned.

LONDON, May 08, 2024 (GLOBE NEWSWIRE) -- WTW (NASDAQ: WTW), a leading global advisory, broking and solutions company, today announces strategic enhancements to its global cyber facility. Following a successful launch in January 2023, WTW’s CyXS facility, a global solution for excess cyber insurance coverage, has introduced new features, effective 1 April 2024, designed to meet the dynamic needs of clients and keep ahead of market trends as cyber risks escalate.

MALVERN, Pa., May 08, 2024 (GLOBE NEWSWIRE) -- Vishay Intertechnology, Inc., (NYSE: VSH), one of the world's largest manufacturers of discrete semiconductors and passive electronic components, today announced results for the fiscal first quarter ended March 30, 2024.

PRESS RELEASE

MINNEAPOLIS, May 08, 2024 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced that it will release its financial results for the first quarter 2024 after the market closes on Wednesday, May 15, 2024. Management will host a webcast/teleconference the same day at 4:30 p.m. Eastern Time to discuss the results and provide a corporate update.

Strong Revenue Growth of 29% Year-over-Year, GAAP Operating Income of $5.4 Million and Adjusted EBITDA of $9.3 Million

Olema will host an investor conference call at 8:00 a.m. ET on May 15, 2024

KING OF PRUSSIA, Pa., May 08, 2024 (GLOBE NEWSWIRE) -- Vertex, Inc. (NASDAQ: VERX) (“Vertex” or the “Company”), a leading global provider of indirect tax solutions, today announced financial results for its first quarter ended March 31, 2024.

CALGARY, Alberta, May 08, 2024 (GLOBE NEWSWIRE) -- Black Diamond Group Limited (TSX: BDI) (“Black Diamond” or the “Company”) announces that it has obtained approval of the Toronto Stock Exchange (the “TSX”) to renew its normal course issuer bid (the “NCIB”) with respect to its common shares (the “Common Shares”). The NCIB will commence on May 10, 2024, and will terminate on the earlier of May 9, 2025, the date on which the Company has purchased the maximum number of Common Shares permitted under the NCIB or the date on which the NCIB is terminated.

Serendipity brings proprietary gene editing assets from the lab of gene editing pioneer Feng Zhang, bolstering Arbor’s diverse toolbox of novel, next-generation editors and expanding potential therapeutic applications in reverse transcriptase-based editing and insertion of large regions of DNA

A strong start to the year following record financial performance in 2023

MURRAY, Utah, May 08, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM) (“R1” or the “Company”), a leading provider of technology-driven solutions that transform the financial performance and patient experience for health systems, hospitals, and physician groups, today announced results for the three months ended March 31, 2024 and updated full year 2024 outlook.

More Than 200 Patients Enrolled in Ongoing SHIELD II Phase 3 Trial of D-PLEX₁₀₀ for the Prevention of Abdominal Colorectal Surgical Site Infections